Page 10 - Precision Medicines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision medicines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Medicines Today - Breaking & Trending Today

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its target price boosted by equities researchers at Jefferies Financial Group from $75.00 to $128.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price objective points to a potential upside […] ....

Jefferies Financial Group , Praxis Precision Medicines Inc , Sphera Funds Management , Vr Adviser , Praxis Precision Medicines Company Profile , Praxis Precision Medicines , Get Free Report , Financial Group , Precision Medicines , Praxis Precision , Asset Management , Funds Management , State Street Corp , Street Corp , Praxis Precision Medicines Daily ,

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Praxis Precision Medicines Company Profile , Vr Adviser , Praxis Precision Medicines Inc , Jefferies Financial Group , Sphera Funds Management , Praxis Precision Medicines , Get Free Report , Financial Group , Precision Medicines , Praxis Precision , Asset Management , Funds Management , State Street Corp , Street Corp , Praxis Precision Medicines Daily ,

Praxis Precision Medicines to Host PRAX-628 Program Update

Presentation will be held virtually on Tuesday, March 26, 2024 at 8:00 a.m. ET Praxis leadership will be joined by key opinion leader in epilepsy Dr. Daniel Friedman, Professor of Neurology at. ....

United States , Daniel Friedman , Globenewswire Inc , Grossman School Of Medicine , Praxis Precision Medicines Inc , Precision Medicines , Praxis Precision Medicines , Media Contact , Science Advisors ,

Short Interest in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Grows By 15.9%

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 564,000 shares, a growth of 15.9% from the January 15th total of 486,700 shares. Approximately 7.1% of the shares of the company are sold short. Based on an […] ....

Group Plc , Praxis Precision Medicines Inc , Principal Financial Group Inc , Barclays Plc , Simplex Trading , Jpmorgan Chase Co , Praxis Precision Medicines , Get Free Report , Truist Financial , Precision Medicines , General Group Plc , Principal Financial Group , Financial Group , Praxis Precision Medicines Daily , Nasdaq Prax ,